Combined treatment of glioblastoma patients with locoregional pre-targeted 90Y-biotin radioimmunotherapy and temozolomide. [electronic resource]
Producer: 20050214Description: 220-8 p. digitalISSN:- 1824-4785
- Antineoplastic Agents, Alkylating -- administration & dosage
- Biotin -- therapeutic use
- Brain Neoplasms -- diagnosis
- Chemotherapy, Adjuvant -- methods
- Combined Modality Therapy
- Dacarbazine -- administration & dosage
- Disease-Free Survival
- Drug Delivery Systems -- methods
- Female
- Glioblastoma -- diagnosis
- Humans
- Italy -- epidemiology
- Male
- Middle Aged
- Radioimmunotherapy -- methods
- Radiopharmaceuticals -- therapeutic use
- Survival Analysis
- Temozolomide
- Treatment Outcome
- Yttrium Radioisotopes -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.